Via: https://theiowastandard.com

On Thursday, the Health and Human Services Department, Department of Labor and Department of the Treasury issued a final rule on price transparency in an effort to assist Americans in knowing how much care will cost in advance and allowing the consumer to make fully informed, value-conscious decisions. The rule requires almost all health insurance […]

Via: https://www.aol.com

In the wake of Charlie Kirk’s assassination earlier this month in Utah, his widow Erika Kirk has stepped into public view with all the force of tragedy and symbolism. During a memorial on September 21, she and Donald Trump shared the stage, with a photo of the two sharing a hug spreading across social media, especially in circles that oppose the current president. At the time, Trump had control of the organization, and detractors suggest Erika was preyed upon by his orbit.

Via: https://youtube.com

The U.S. Department of Justice has released over 3 million pages of documents connected to the Jeffrey Epstein investigation. The newly unsealed files reference several high-profile figures, including President Donald Trump, Elon Musk, Bill Clinton, and a former Obama White House counsel. The release includes an FBI list of allegations involving Trump, many based on unverified tips. The White House cited a Justice Department statement calling the claims “unfounded and false,” and Trump has repeatedly denied any connection to wrongdoing. Deputy Attorney General Todd Blanche confirmed the DOJ has completed its review of the Epstein files and stated the White House had no role or oversight in the process. Thank you again for watching! Be sure to Like, Comment, Share, and Subscribe to the channel! Click the ???? icon to receive notifications when I go LIVE or upload new content. Support My Channel Here is the Link to support my channel: https://linktr.ee/LTLMedia Follow Me on Social Media Stay connected across platforms Twitter - https://twitter.com/letstalkliveytc Facebook - https://www.facebook.com/ltlmediainc Have a Question or Comment? Feel free to reach out to me via email - letstalklivepodcast@gmail.com Copyright Disclaimer Under **Section 107** of the **Copyright Act of 1976**, allowance is made for **"fair use"** for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. This use is permitted by copyright statute, even if it might otherwise be infringing. Non-profit, educational, or personal use tips the balance in favor of fair use. I do not authorize the use of any of my videos, images, prose, or related content without express prior authorization. For permission requests, please email me at: letstalklivepodcast@gmail.com ????️ New to streaming or looking to level up? Check out StreamYard and get $10 discount! ???? https://streamyard.com/pal/d/5175057208049664

Via: https://ctmirror.org

President Donald Trump initially tied support to President Javier Milei’s performance in the October election in Argentina.

Via: https://youtube.com

KILNE’s rework of Dolores, performed at the X Factory, Stoke-on-Trent, UK. Produced with support from ARTS COUNCIL ENGLAND and URBAN WILDERNESS. Thank you to our friends at STAGG and LEVANTE for your continued support. // FOLLOW KILNE Facebook: @kilneband Instagram: @kilneband // MUSIC CREDITS Arranged by Ben Oakes & Danny Shaw Written by Arthur Wagner Recorded by Mark Eyden at Sun Street Studios Mixed by Mark Eyden Performed by… Trumpet: Fee Buckton, Paul Bennett, Tez Smith Tenor Saxophone: Ben Oakes, Oliver Pritchard Jones Tenor Trombone: Helen Miller, Lewis Topping Baritone Saxophone: John Mageean Bass Saxophone: Chris Davies Tuba: Paul Hughes Snare Drum: Danny Shaw Bass Drum: Cael Ralph Surdo Drums: Adam Jones, Jay Hargreaves, Jordan Wright, Kian Mundy, Nathan Thomas Crash: Joe Wood Marimba: Tristan Butler // VIDEO CREDITS Filmed by Bertie Baxter Edited by Cael Ralph

Via: https://youtube.com

President Trump reacted to Attorney General William P. Barr's summary of the Mueller report on March 24. Subscribe to The Washington Post on YouTube: https://wapo.st/2QOdcqK Follow us: Twitter: https://twitter.com/washingtonpost Instagram: https://www.instagram.com/washingtonpost/ Facebook: https://www.facebook.com/washingtonpost/

Via: https://afnn.us

When Will You Go to Jail? The FBI recently made 50 searches of former Trump Administration officials. The FBI is fishing, most likely, for anything that can be glued together for a conspiracy charge concerning the “January 6th” election process or mob. If the Feds are going after Trump officials, when will they come for you? And, what Federal outrage does it take for you to be willing to go to jail for your beliefs?

Via: https://bsky.app

NEW: The great Trump-Musk crackdown is coming. And it will hit hard & fast. Journalists will be first. But everyone else is next. I urge you to read my 20 lessons in How to Survive the Broligarchy, inspired by & featuring the great @timothysnyder.bsky.social 1/ https://www.theguardian.com/commentisfree/2024/nov/17/how-to-survive-the-broligarchy-20-lessons-for-the-post-truth-world-donald-trump

Via: http://educationblogit.blogspot.com

George Clooney just announced his new mission in life and it is actually a gift to Trump in disguise. Clooney, like most Hollywood hot ...

Via: https://theiowastandard.com

From Donald J. Trump: THE FACTS: This is a Witch-Hunt – President Trump is completely innocent. This is election interference – Radical Left Democrats and the New York District Attorney’s office are politicizing our justice system to influence the 2024 Presidential race. This is unprecedented – never before has a former President been charged. WITCH-HUNT: This isn’t a […]

Via: https://ca.news.yahoo.com

"I can be very military," the former president once wrote in a 2013 Facebook post.

Via: https://actionnetwork.org/letters/tell-congress-investigate-trumps-14-billion-profit-from-the-presidency/?source=group-democracy-for-america-advocacy-fund&referrer=group-democracy-for-america-advocacy-fund&redirect=https://hollywooddemocrats.donorsupport.co

Via: https://youtube.com

► Stream / Double LP vinyl / Blu-ray / Merch: https://ffm.to/unspokenwords_.oyd ► Sign up & join Mesh Discord: https://os.fan/MaxCooper/SignUp ► More project info: https://unspokenwords.net/integration Max Cooper: The final chaoter of the Unspoken Words Atmos film, now we look outward and the narrative is completed as the emergent mind returns to its home in the wider system that created it. I was trying to communicate the feeling of perspective with the music. Us, as individuals, as a tiny speck looking out into the vastness, but also, occupying it. It was written with this theme for a reason, having originated from a very unusual job. I was asked to make music for a UN summit focused on climate action, where world leaders would sit with eyes closed and listen to the piece. It was the Trump era at the time, and so my task was how to bring the giant egos into check, how could I make them feel small and the natural world feel relevant? Of course I would have failed, and in the end the brief changed (resulting in the “Imagine for 1 minute” project with Pope Francis, Greta Thunberg and others narrating), but I was left with this piece of music which I had a approached from a very particular perspective which lent itself to the Unspoken Words project and the closing sequence of the film version of the album. I was extremely happy to find out that my long term collaborator and master of epic scales, Thomas Vanz, was interested in the idea and the piece of music. Thomas created a continuation of the story from our “Hope” collaboration (from the album/project ‘One Hundred Billion Sparks’)*, which looks at internal neuronal processes, finishing with the eye. Now we start with the eye where that left off, and look out of the body into the vastness as only Thomas can, with his secret concoctions of chemicals yielding chaotic fractal processes which tie the aesthetics of the micro to the macro scales of our surroundings. *("Hope": https://www.youtube.com/watch?v=-eZLJLVqWwM) The story of Unspoken Words ends with our final expansion, and a fictional resolution to the human condition of escaping all constraints. CREDITS: Music: Max Cooper, https://maxcooper.net Visuals: Thomas Vanz, https://www.thomasvanz.com/ Label: Mesh, https://meshmeshmesh.net

Via: https://youtube.com

Delaware County String Band recording of "The Fightin' Phils" transferred by PhilaVideo from a 78 record. Song written by bandleader Elliot Lawrence and arranger Bix Reichner. It sold over 5,000 copies during the 1950 season. The recording was intended to be strictly a publicity stunt and the Elliot Lawrence band never actually recorded the song. If I am not mistaken, this is the only recording of the song ever made. The video is a home movie of the Elliot Lawrence band at Shibe Park on April 18, 1950; the Elliot Lawrence band performs at Shibe Park on Opening Day of 1950 with the Phillies hosting the Dodgers which explains the bunting throughout the stadium. The short bit of game action shows Robin Roberts walking to the mound and Richie Ashburn scoring from first on a double to center by Granny Hamner off Don Newcombe. Phillies won this day 9-1. From a home movie by drummer Howie Mann. Soundtrack: Elliot explains how they played at the Opening Day of the 1950 season on the "Land's Best bands" transcription disc. Don Wilson, announcer. Don Wilson was the announcer for the Jack Benny program. This film shows the band waiting for the game to start, the band performing their version of the "Fightin' Phils" and segments of the actual game. Members of the band watch the game from the stands. My father Joe Techner plays the trumpet at 00:51 and waves at the camera at 00:36. Film transferred from original 8mm film by PhilaVideo. Music record transferred by PhilaVideo from original 78 disc using a chronological equalizer.

Via: https://youtube.com

Quelle : https://youtu.be/JilrzztcDKA

Via: https://apnews.com

WASHINGTON (AP) — In an extraordinary indictment, the U.S. special counsel accused 13 Russians Friday of an elaborate plot to disrupt the 2016 presidential election, charging them with running a huge but hidden social media trolling campaign aimed in part at helping Republican Donald Trump defeat De

Via: https://www.axios.com

Via: https://www.change.org

Via: https://theconversation.com

Confidentiality is written into the code of ethics that governs the profession. Will Congress force them to break it to learn the contents of Trump’s private meetings?

Via: https://finance.yahoo.com

(Bloomberg) -- Zhang Haitao was a basketball-loving teenager who dreamed of going to a specialized sports high school when he got a pain in his right arm that just wouldn’t go away. It turned out to be acute lymphoblastic leukemia.The discovery set Zhang and his family, from a village deep in the mountains of southwestern China's Sichuan province, on a journey familiar to most cancer patients — a revolving door of hospital visits, blood tests and three rounds of chemotherapy. It was then that Zhang’s doctor suggested a last-ditch option: an experimental gene therapy being trialed by a Chinese startup called Gracell Biotechnology Ltd.After spending three weeks in the hospital in May — during which white blood cells were removed from his body, genetically engineered, and then infused back in — an analysis of Zhang’s bone marrow in June showed his body was clear of cancer.Seven months later, monthly medical tests conducted at a hospital in the nearby Chinese metropolis of Chongqing show he remains cancer free. “I don’t remember much about the treatment as I had a fever throughout,” said Zhang, who’s now almost 16 and spends his days playing video games and texting his friends. “It seems like a new solution that will give people hope.”Read more about how China is overhauling its healthcare systemThe therapy Zhang received was Chimeric Antigen Receptor-T cells, known as CAR-T, and it’s being hailed as one of the most exciting developments in the quest to cure cancer. First developed by Israeli scientist Zelig Eshhar in the 1980s, CAR-T re-works the genes of the body’s own immune cells so that they actively seek out and destroy cancer cells. While it’s been embraced by researchers and drugmakers around the world, perhaps nowhere is CAR-T having more impact — and being pushed dangerously close to its limits — than in China, home to the world’s biggest cancer population and some of the most ambitious experiments.CAR-T works by supercharging T-cells, the body’s main line of defense against disease, so that they latch onto and destroy cancer. In clinical trials, leukemia patients who failed to respond to other therapies have shown remission rates of over 90% within two months of treatment.Though drug giants Novartis AG and Gilead Sciences Inc. have been marketing CAR-T globally since 2017, it’s expensive. The process of engineering an individual’s cells in a laboratory and then replicating them has also meant that some patients with more aggressive cancers can die waiting for treatment.That’s where Gracell’s therapy was revolutionary. Instead of the two to three weeks taken by current treatments from American and European drug makers, the Shanghai-based company — set up by a group of veteran Chinese cell-therapy researchers — is churning out cancer-killing immune cells overnight.And they’re doing it much cheaper in some cases than global pharmaceutical giants. Gracell has developed a process using genetic engineering that speeds up the cell production stage, according to founder William Cao Wei. Gracell plans to price its CAR-T treatment for about 500,000 yuan ($71,000), well below the $475,000 price tag for Novartis’ Kymriah, the Swiss company’s CAR-T therapy used to treat the type of blood cancer that Zhang had. A similar treatment from Gilead, based in Foster City, California, costs $373,000.The aging population and a raft of lifestyle factors mean that more new cancer patients are emerging in China than anyplace else in the world, giving the country a significant stake in the global fight to find a cure. Emboldened by the government’s push to become a scientific superpower and to dominate the field of genetics, Gracell and other Chinese biotech startups are racing ahead, with China likely to approve CAR-T for widespread use as early as next year. Up for grabs is a market for cancer drugs and experimental treatments that has exploded to $133 billion a year worldwide, according to life sciences researcher Iqvia Institute.“There can be both cooperation and competition between us and CAR-T developers in developed markets,” said Cao, who is also Gracell’s chief executive officer. “But there will definitely be competition.” That drive to forge ahead — and in front — can be seen in the way China is approaching regulation of CAR-T. The country is weighing new rules that would loosen oversight of the revolutionary technology, allowing academic ethics committees within hospitals to approve new CAR-T treatments and then administer them to patients for a fee.That would markedly loosen China’s current framework, which is presently in line with the approach taken by regulatory bodies like the U.S Food and Drug Administration and the European Medicines Agency. These entities are the sole authorities in their jurisdictions that evaluate and approve all CAR-T therapies before they are cleared for public use.There is concern among researchers, regulatory experts and drugmakers themselves that allowing hospitals to market treatments for a fee could cause profit-making to trump ethical considerations. In a 2016 case widely reported in the Chinese media, a 22-year-old college student with a rare type of tissue cancer called synovial sarcoma died after going through an experimental cell therapy at a Beijing hospital.“Hospitals can become both players and referees at the same time”Before his death, the patient posted an essay online claiming the hospital had falsely advertised the treatment’s effectiveness, and that Chinese search engine Baidu Inc. had displayed the hospital’s advertising so that it appeared like a credible search result rather than a paid commercial. The essay went viral and sparked an outcry on Chinese social media over the ethics of private hospitals and the regulation of therapies for serious illnesses.Censured by the Cyberspace Administration of China, Baidu responded by restricting the number of sponsored posts to 30% of a results page, and established a 1 billion yuan fund to fight fraud. The hospital did not respond to requests for comment.It’s not the only death allegedly linked to genetic cell therapy in China. Last year, a hospital in the eastern city of Xuzhou was sued over the death of a lymphoma patient who died after receiving a CAR-T treatment. The patient developed severe side effects, including bleeding within the abdomen. The patient’s family argued that the treatment led to his death, but the hospital and doctor said it was the result of late-stage cancer. A court is yet to rule on the case.China’s proposed new framework is reminiscent of its wider approach to the regulation of science, an area President Xi Jinping has prioritized as part of his ambition to cement the country as a world power.The research of He Jiankui, an American-educated Chinese scientist whose revelation last year that he’d edited the genes of twin baby girls ignited a global firestorm, was signed off by the ethics committee of a Shenzhen hospital. The experiment, which He claimed made the twins immune to HIV, wasn’t backed by peer-reviewed data and still hasn’t been verified. Scientists around the world have condemned it as an irresponsible use of a technology that has the capacity to alter the very building blocks of life. The long-term effects of Crispr, the gene-snipping tool used by He and embraced by Chinese researchers, are also yet to be fully understood.China’s new draft rules on CAR-T could give rise to the same scenario, critics say.There’s no guarantee that the hospital committees have the qualifications to evaluate such a complicated therapy, said Tao Xin, a Washington, D.C.-based lawyer at Hogan Lovells LLP who specializes in the health-care regulatory law of both the U.S. and China.“The proposal indicates that hospitals can charge a fee for the therapy, in addition to approving its own therapy,” he said. “With these two combined, are we going to see a replay of the 2016 incident? If there’s money to be made and I get to decide whether to do it or not, that’s really controversial.”Read about how Crispr is being used in China’s quest to make a super pigGracell’s Cao is also critical of the new framework as it removes the role of an independent entity that evaluates the therapy’s safety and efficacy: “Hospitals can become both players and referees at the same time.”Novartis and Gilead declined to comment on China’s regulatory plans, while a spokesman for the National Health Commission, the body in charge of governing the country’s health sector, said that the proposed new rules are still under discussion.Read about how Chinese parents are using DNA tests to map out their children’s livesMeanwhile, Chinese companies are racing ahead on CAR-T and attracting hundreds of millions of dollars from investors like Singapore’s sovereign wealth fund Temasek Holdings Pte Ltd, as well as global pharmaceutical giants. Venture capital investment in Chinese biotech firms climbed to $17.6 billion last year, quadruple the amount from 2015, according to consultancy ChinaBio LLC. Gracell — which counts Temasek and Lilly Asia Ventures, the venture capital firm spun off from Eli Lilly & Co. as investors — says 32 of the 35 patients it’s enrolled in its China-based trials over the past year have gone into complete remission “with minimal residual disease tested negative” four weeks after the CAR-T infusion — a clinical term that basically means there was no evidence of disease remaining in their bodies, the highest possible efficacy level for a therapy.Other Chinese startups like Nanjing Legend, a unit of Hong Kong-listed Genscript Biotech Corp., and U.S.-listed Cellular Biomedicine Group Inc., have developed similar capabilities.In 2018, Novartis paid $40 million for a 9% stake in Shanghai-based Cellular Biomedicine, and will use their cell therapy facility to manufacture its Kymriah treatment, which is currently being assessed for approval by China’s drug regulator. The startup is also developing its own CAR-T therapies and testing their potential against solid tumors, not just blood cancers. Chief Executive Officer Tony Liu Bizuo said Cellular Biomedicine’s digitized and automated process cuts the cell engineering time from four weeks to less than 10 days.Cellular Biomedicine is now mulling building a bigger cell production facility with the Shanghai government, as demand for cell therapy grows and on expectations more commercial CAR-T treatments will be approved in China in the coming years. In a sign of the support startups are getting from the authorities, the city’s government has earmarked a 4 million square feet space for cell therapy research. Of the 21 cell therapies currently in clinical trials approved by China’s drug regulator, 11 are being conducted in the lab, which is fast becoming the nation’s CAR-T Ground Zero.The next frontier is to make CAR-T as accessible as any other drug, and Chinese startups are at the leading edge. Dubbed “universal CAR-T,” this involves finding a way to take T-cells from healthy people and engineering them so that they can be infused into any cancer patient. Gracell is studying the use of donor white blood cells, marking a step toward that goal. Other startups like French company Cellectis SA are also racing to make universal CAR-T a reality.“I’m very impressed with the pace of technological progress in China and the expansion of CAR-T research coming so rapidly,” said Bruce Levine, a professor specializing in cancer gene therapy at the Perelman School of Medicine at the University of Pennsylvania.“We all want these therapies to move fast and some are very good, but we need to be aware that some could be moving too fast for their expertise, even if they have very good intentions,“ he said.Read about how a Chinese genetics giant wants to tailor drugs to people’s DNAAfter a year in and out of hospital, Zhang, the teenage cancer patient in Chongqing, is starting to make plans for the future. If it wasn’t for the leukemia, he’d be in his first year of high school now.“I don’t think I can go to sports school anymore, but I hope to learn a professional skill,” said Zhang, who’s now a foot taller than his aunt, Chen Chunhua, his primary caregiver. “I want to grasp this chance I have.”While China’s approach to CAR-T may be criticized as moving too fast, Chen, who left her job at a ceramics factory to care for Zhang when he got sick, is thankful he had access to the treatment, which wouldn’t have been possible in China had the boy fallen ill just a year earlier.“I’m so happy we had this option within China,” she said. “It really helps to lessen our burden.”  \--With assistance from Dong Lyu.To contact the editor responsible for this story: Rachel Chang at wchang98@bloomberg.net, Anjali CordeiroFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.

Via: https://www.wsj.com

Via: https://www.medi.de

Kompressionsstrümpfe richtig anziehen – mit und ohne Anziehhilfe, so klappt es ganz einfach.

Via: https://carnegieendowment.org

It is not the incivility of modern politics that drives some to question Trump’s fitness for the presidency; it is a respect for the lessons of history and for the national interests his profound deficits put at risk.

Via: https://youtube.com

Provided to YouTube by Columbia Ta Bouche Est Tabou · Poi Dog Pondering Volo Volo ℗ 1991 Sony Music Entertainment Inc. Released on: 1992-03-03 Composer, Lyricist: J.F. Berneron Background Vocal, Violin: Susan Mary Voelz Background Vocal, Bells, Congas, Shaker: John Nelson Background Vocal: Abra Moore Guitar: Adam Sultan Guitar: Ted Cho Drums: Daren Hess Accordion, Fluegelhorn, Organ, Piano, Trumpet: Dave Crawford Tenor Saxophone: John Mills Trombone: Jon Blondell Producer: Jerry Harrison Assistant Engineer: Stuart Sullivan Assistant Engineer: Bobby Arnolds Assistant Engineer: Doug McKean Mixing Engineer: Alan Winstanley Recording Engineer: David Vartanian Auto-generated by YouTube.

Via: https://youtube.com

Below is the opening statement from Robert Mueller, Former Special Counsel for the United States Department of Justice. "Good morning Chairman Nadler, Ranking Member Collins, and members of the Committee. As you know, in May 2017, the Acting Attorney General asked me to serve as Special Counsel. I undertook that role because I believed that it was of paramount interest to the nation to determine whether a foreign adversary had interfered in the presidential election. As the Acting Attorney General said at the time, the appointment was “necessary in order for the American people to have full confidence in the outcome.” My staff and I carried out this assignment with that critical objective in mind: to work quietly, thoroughly, and with integrity so that the public would have full confidence in the outcome. The order appointing me as Special Counsel directed our Office to investigate Russian interference in the 2016 presidential election. This included investigating any links or coordination between the Russian government and individuals associated with the Trump campaign. It also included investigating efforts to interfere with, or obstruct, the investigation. Throughout the investigation, I continually stressed two things to the team that we had assembled. First, we needed to do our work as thoroughly as possible and as expeditiously as possible. It was in the public interest for our investigation to be complete, but not to last a day longer than necessary. Second, the investigation needed to be conducted fairly and with absolute integrity. Our team would not leak or take other actions that could compromise the integrity of our work. All decisions were made based on the facts and the law. During the course of our investigation, we charged more than 30 defendants with committing federal crimes, including 12 officers of the Russian military. Seven defendants have been convicted or pled guilty. Certain of the charges we brought remain pending today. For those matters, I stress that the indictments contain allegations, and every defendant is presumed innocent unless and until proven guilty. In addition to the criminal charges we brought, as required by Justice Department regulations, we submitted a confidential report to the Attorney General at the conclusion of the investigation. The report set forth the results of our work and the reasons for our charging and declination decisions. The Attorney General later made the report largely public. As you know, I made a few limited remarks about our report when we closed the Special Counsel’s Office in May of this year. There are certain points that bear emphasis. First, our investigation found that the Russian government interfered in our election in sweeping and systematic fashion. Second, the investigation did not establish that members of the Trump campaign conspired with the Russian government in its election interference activities. We did not address “collusion,” which is not a legal term. Rather, we focused on whether the evidence was sufficient to charge any member of the campaign with taking part in a criminal conspiracy. It was not. Third, our investigation of efforts to obstruct the investigation and lie to investigators was of critical importance. Obstruction of justice strikes at the core of the government’s effort to find the truth and to hold wrongdoers accountable. Finally, as described in Volume 2 of our report, we investigated a series of actions by the President towards the investigation. Based on Justice Department policy and principles of fairness, we decided we would not make a determination as to whether the President committed a crime. That was our decision then and it remains our decision today." ►Subscribe: https://on.wtsp.com/youtube ►Website: https://www.wtsp.com/ ►Facebook: https://www.facebook.com/10NewsWTSP/ ►Twitter: https://twitter.com/10NewsWTSP 10News WTSP is the local CBS affiliate for Tampa Bay, Florida. We deliver the best in breaking news, live video coverage, and original journalism covering topics that matter most to Floridians. Subscribe for more; videos are updated daily!

Via: https://youtube.com

Via: https://youtube.com

#antitrump #news #apocalypse

Via: https://www.hkgpao.com

日本首相高市早苗3月21日結束訪美行程回國，照例大肆宣揚美日同盟怎麼好，包括在X發帖表示，這次訪問「意義深遠，確認了進一步強化日美同盟以及邁向兩國經濟發展的具體路線」。不過，日本人看到，高市早苗行程中的經歷及表現，似乎對所謂的美日關係不很樂觀。 最明顯的是，美國總統特朗普在白宮接待高市早苗時，回應記者提問為何攻打伊朗前沒通知包括日本在內的盟友，特朗普竟然講起地獄笑話，表示他們想要出其不意，「還有誰比日本更懂得出其不意呢？為甚麼你不跟我說說珍珠港？」拿日本二戰軍國主義失心瘋時偷襲珍珠港事件開玩笑，搞得高市早苗表情控制機能當場崩潰，事後日本人普遍不好受，日本網民不理會特朗普回話得不得體，而是歸究記者問得差。 第二個例子，就是白宮網站發表高市早苗訪美的照片，其中一張特別選了高市早苗在白宮宴會廳跟隨音樂手舞足蹈的奇怪樣子，引發廣泛討論。不少人認為，白宮是故意如此，是另一次的故意羞辱，也把高市早苗的媚美外交表露無遺。 有分析認為，特朗普擅長（或曰喜歡）通過羞辱盟友，挖盟友瘡疤，從而確立自己的主導地位，用使對方難堪的做法來獲取勢，迫盟友讓步。那麼問題來了：高市早苗跪舔式訪美，換回來的卻是特朗普政府百般羞辱，高市早苗的外交，是為日本爭光？「忍辱負重」？還是使日本出了一個大醜？這種由開始到今天依然不平等的關係，說好的美日友好、美日同盟，本質上又是什麼呢？值得日本人好好思考。 原圖：白宮網站 https://www.whitehouse.gov/gallery/president-donald-j-trump-and-japanese-prime-minister-sanae-takaichi-deliver-remarks-in-the-the-state-dining-room/  

Via: https://youtube.com

Supergoods - Discoentelechy Produced by Jean-David Caillouët & Supergoods Recorded and Mixed by Jean-David Caillouët Mastered by Bernie Grundman Recorded by Jean-David Caillouët - Zoo Studio, Bangkok Rhythm section with Wittawin Win Amonrattanasak at Cold Brew Studio, Bangkok Brass recorded with Lertrit Klinthoop and Tommy Hanson at TMM studio Strings recorded with Patrick Chinnawong at TM studio, Bangkok. Additional Musicians Tawatchai Rungrojsoontorn - Bass Ganokpong Tantisaewee - Electric piano Jean-David Caillouët - Synthesizer Rudi Samansap - Trumpet Puchiss Mayod - Alto Saxophone Anecha Sinsaart - Tenor Saxophone Jirapahn Khaokum - Violin Anna Olsson - Violin Phanupong Sermpongpaisal - Viola Rapeepat Munyanon - Cello Animation by Jain Chonpicha ---------------------------- "Discoentelechy" will set you free From the reality that you can't understand. "Discoentelechy" firm from the core Every broken piece, still fabulous forever. Fusion divine, Sparkle and shine, Heavenly tide, (Shimmering light) Music collides. Embrace the rhyme. Express your soul, You'll find your role "Discoentelechy will set you free" Escape the gravity that keeps your desires bound "Discoentelechy" firm from the core Every broken piece, still fabulous forever. Come as you are, shed your worries, fears and tears. ---------------------------- POY Records

Via: https://youtube.com

Dive deep into the book of Revelation in this thorough study of one of the most mysterious and feared figures in the scriptures. Abaddon, also known as Apollyon, the angel of the abyss. This video offers a detailed analysis of the theological meanings and spiritual implications associated with this enigmatic being, whose name symbolizes destruction and who plays a crucial role in the events of the end times. What you will discover in this video: Identity and Meaning: Understand who Abaddon/Apollyon is through an exploration of his names in Hebrew and Greek and the role they play in the apocalyptic narrative. Differences between Abaddon/Apollyon and Satan: Explore how Abaddon/Apollyon differs from Satan, illustrating the complex hierarchy of spiritual forces described in the Bible. Eschatological Impact: Discover the impact of the release of Abaddon/Apollyon during the sounding of the fifth trumpet and how it affects those without the seal of God. Implications for Christians Today: Reflect on how understanding such spiritual entities can influence our vigilance and faith in times of tribulation. This video is not just a biblical study; it is a call for reflection and deep understanding of the forces that shape our spiritual and physical world. If you seek to comprehend the mysteries of Revelation and strengthen your faith through knowledge of the Scriptures, this video is essential. Don't forget to subscribe to the channel, leave your like, and comment with your questions or insights. Share this video with friends and family interested in deepening their understanding of the word of God and facing life's challenges with renewed faith.